The Market Reports

Index

1 Non-Invasive Blood Glucose Monitoring Devices Market Overview
1.1 Product Overview and Scope of Non-Invasive Blood Glucose Monitoring Devices
1.2 Non-Invasive Blood Glucose Monitoring Devices Segment by Type
1.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 MIR/NIR (Mid/Near Infrared Spectroscopy)
1.2.3 Raman Spectroscopy
1.2.4 Occlusion Spectroscopy
1.2.5 Optical Coherence Tomography
1.2.6 Photoacoustic Spectroscopy
1.2.7 Electromagnetic
1.2.8 Fluorescence
1.2.9 Other
1.3 Non-Invasive Blood Glucose Monitoring Devices Segment by Application
1.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.3.5 Other
1.4 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue 2016-2027
1.4.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales 2016-2027
1.4.3 Non-Invasive Blood Glucose Monitoring Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-Invasive Blood Glucose Monitoring Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-Invasive Blood Glucose Monitoring Devices Manufacturing Sites, Area Served, Product Type
2.5 Non-Invasive Blood Glucose Monitoring Devices Market Competitive Situation and Trends
2.5.1 Non-Invasive Blood Glucose Monitoring Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-Invasive Blood Glucose Monitoring Devices Players Market Share by Revenue
2.5.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-Invasive Blood Glucose Monitoring Devices Retrospective Market Scenario by Region
3.1 Global Non-Invasive Blood Glucose Monitoring Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Non-Invasive Blood Glucose Monitoring Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.3.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales by Country
3.3.2 North America Non-Invasive Blood Glucose Monitoring Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.4.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales by Country
3.4.2 Europe Non-Invasive Blood Glucose Monitoring Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales by Region
3.5.2 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.6.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales by Country
3.6.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales by Country
3.7.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Analysis by Type
4.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Type (2016-2021)
4.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Type (2016-2021)
4.3 Global Non-Invasive Blood Glucose Monitoring Devices Price by Type (2016-2021)

5 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Analysis by Application
5.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Application (2016-2021)
5.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Application (2016-2021)
5.3 Global Non-Invasive Blood Glucose Monitoring Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 BD Medical
6.2.1 BD Medical Corporation Information
6.2.2 BD Medical Description and Business Overview
6.2.3 BD Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 BD Medical Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.2.5 BD Medical Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medtronic Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Roche Diagnostics
6.5.1 Roche Diagnostics Corporation Information
6.5.2 Roche Diagnostics Description and Business Overview
6.5.3 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.5.5 Roche Diagnostics Recent Developments/Updates
6.6 Animas Technologies
6.6.1 Animas Technologies Corporation Information
6.6.2 Animas Technologies Description and Business Overview
6.6.3 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.6.5 Animas Technologies Recent Developments/Updates
6.7 Bayer Healthcare
6.6.1 Bayer Healthcare Corporation Information
6.6.2 Bayer Healthcare Description and Business Overview
6.6.3 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.7.5 Bayer Healthcare Recent Developments/Updates
6.8 Cercacor
6.8.1 Cercacor Corporation Information
6.8.2 Cercacor Description and Business Overview
6.8.3 Cercacor Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Cercacor Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.8.5 Cercacor Recent Developments/Updates
6.9 Pendragon Medical
6.9.1 Pendragon Medical Corporation Information
6.9.2 Pendragon Medical Description and Business Overview
6.9.3 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.9.5 Pendragon Medical Recent Developments/Updates
6.10 OrSense
6.10.1 OrSense Corporation Information
6.10.2 OrSense Description and Business Overview
6.10.3 OrSense Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 OrSense Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.10.5 OrSense Recent Developments/Updates
6.11 Nova Biomedical
6.11.1 Nova Biomedical Corporation Information
6.11.2 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Description and Business Overview
6.11.3 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.11.5 Nova Biomedical Recent Developments/Updates
6.12 Dexcom
6.12.1 Dexcom Corporation Information
6.12.2 Dexcom Non-Invasive Blood Glucose Monitoring Devices Description and Business Overview
6.12.3 Dexcom Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Dexcom Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.12.5 Dexcom Recent Developments/Updates
6.13 Terumo
6.13.1 Terumo Corporation Information
6.13.2 Terumo Non-Invasive Blood Glucose Monitoring Devices Description and Business Overview
6.13.3 Terumo Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Terumo Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.13.5 Terumo Recent Developments/Updates
6.14 Tosoh Bioscience
6.14.1 Tosoh Bioscience Corporation Information
6.14.2 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Description and Business Overview
6.14.3 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.14.5 Tosoh Bioscience Recent Developments/Updates

7 Non-Invasive Blood Glucose Monitoring Devices Manufacturing Cost Analysis
7.1 Non-Invasive Blood Glucose Monitoring Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-Invasive Blood Glucose Monitoring Devices
7.4 Non-Invasive Blood Glucose Monitoring Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-Invasive Blood Glucose Monitoring Devices Distributors List
8.3 Non-Invasive Blood Glucose Monitoring Devices Customers

9 Non-Invasive Blood Glucose Monitoring Devices Market Dynamics
9.1 Non-Invasive Blood Glucose Monitoring Devices Industry Trends
9.2 Non-Invasive Blood Glucose Monitoring Devices Growth Drivers
9.3 Non-Invasive Blood Glucose Monitoring Devices Market Challenges
9.4 Non-Invasive Blood Glucose Monitoring Devices Market Restraints

10 Global Market Forecast
10.1 Non-Invasive Blood Glucose Monitoring Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-Invasive Blood Glucose Monitoring Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Non-Invasive Blood Glucose Monitoring Devices by Type (2022-2027)
10.2 Non-Invasive Blood Glucose Monitoring Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-Invasive Blood Glucose Monitoring Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Non-Invasive Blood Glucose Monitoring Devices by Application (2022-2027)
10.3 Non-Invasive Blood Glucose Monitoring Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-Invasive Blood Glucose Monitoring Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Non-Invasive Blood Glucose Monitoring Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Non-Invasive Blood Glucose Monitoring Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non-Invasive Blood Glucose Monitoring Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non-Invasive Blood Glucose Monitoring Devices Covered in This Study
Table 5. Global Non-Invasive Blood Glucose Monitoring Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Non-Invasive Blood Glucose Monitoring Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-Invasive Blood Glucose Monitoring Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-Invasive Blood Glucose Monitoring Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Non-Invasive Blood Glucose Monitoring Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-Invasive Blood Glucose Monitoring Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Blood Glucose Monitoring Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-Invasive Blood Glucose Monitoring Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Region (2016-2021)
Table 17. Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Country (2016-2021)
Table 20. North America Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Non-Invasive Blood Glucose Monitoring Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Type (2016-2021)
Table 40. Global Non-Invasive Blood Glucose Monitoring Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Share by Type (2016-2021)
Table 42. Global Non-Invasive Blood Glucose Monitoring Devices Price (USD/Unit) by Type (2016-2021)
Table 43. Global Non-Invasive Blood Glucose Monitoring Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Application (2016-2021)
Table 45. Global Non-Invasive Blood Glucose Monitoring Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Share by Application (2016-2021)
Table 47. Global Non-Invasive Blood Glucose Monitoring Devices Price (USD/Unit) by Application (2016-2021)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Business Overview
Table 50. Abbott Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Non-Invasive Blood Glucose Monitoring Devices Product
Table 52. Abbott Recent Developments/Updates
Table 53. BD Medical Corporation Information
Table 54. BD Medical Description and Business Overview
Table 55. BD Medical Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. BD Medical Non-Invasive Blood Glucose Monitoring Devices Product
Table 57. BD Medical Recent Developments/Updates
Table 58. Medtronic Corporation Information
Table 59. Medtronic Description and Business Overview
Table 60. Medtronic Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Medtronic Non-Invasive Blood Glucose Monitoring Devices Product
Table 62. Medtronic Recent Developments/Updates
Table 63. Sanofi Corporation Information
Table 64. Sanofi Description and Business Overview
Table 65. Sanofi Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Sanofi Non-Invasive Blood Glucose Monitoring Devices Product
Table 67. Sanofi Recent Developments/Updates
Table 68. Roche Diagnostics Corporation Information
Table 69. Roche Diagnostics Description and Business Overview
Table 70. Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Product
Table 72. Roche Diagnostics Recent Developments/Updates
Table 73. Animas Technologies Corporation Information
Table 74. Animas Technologies Description and Business Overview
Table 75. Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Product
Table 77. Animas Technologies Recent Developments/Updates
Table 78. Bayer Healthcare Corporation Information
Table 79. Bayer Healthcare Description and Business Overview
Table 80. Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Product
Table 82. Bayer Healthcare Recent Developments/Updates
Table 83. Cercacor Corporation Information
Table 84. Cercacor Description and Business Overview
Table 85. Cercacor Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Cercacor Non-Invasive Blood Glucose Monitoring Devices Product
Table 87. Cercacor Recent Developments/Updates
Table 88. Pendragon Medical Corporation Information
Table 89. Pendragon Medical Description and Business Overview
Table 90. Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Product
Table 92. Pendragon Medical Recent Developments/Updates
Table 93. OrSense Corporation Information
Table 94. OrSense Description and Business Overview
Table 95. OrSense Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. OrSense Non-Invasive Blood Glucose Monitoring Devices Product
Table 97. OrSense Recent Developments/Updates
Table 98. Nova Biomedical Corporation Information
Table 99. Nova Biomedical Description and Business Overview
Table 100. Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Product
Table 102. Nova Biomedical Recent Developments/Updates
Table 103. Dexcom Corporation Information
Table 104. Dexcom Description and Business Overview
Table 105. Dexcom Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Dexcom Non-Invasive Blood Glucose Monitoring Devices Product
Table 107. Dexcom Recent Developments/Updates
Table 108. Terumo Corporation Information
Table 109. Terumo Description and Business Overview
Table 110. Terumo Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Terumo Non-Invasive Blood Glucose Monitoring Devices Product
Table 112. Terumo Recent Developments/Updates
Table 113. Tosoh Bioscience Corporation Information
Table 114. Tosoh Bioscience Description and Business Overview
Table 115. Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Product
Table 117. Tosoh Bioscience Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Non-Invasive Blood Glucose Monitoring Devices Distributors List
Table 121. Non-Invasive Blood Glucose Monitoring Devices Customers List
Table 122. Non-Invasive Blood Glucose Monitoring Devices Market Trends
Table 123. Non-Invasive Blood Glucose Monitoring Devices Growth Drivers
Table 124. Non-Invasive Blood Glucose Monitoring Devices Market Challenges
Table 125. Non-Invasive Blood Glucose Monitoring Devices Market Restraints
Table 126. Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 127. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share Forecast by Type (2022-2027)
Table 128. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 129. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share Forecast by Type (2022-2027)
Table 130. Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 131. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share Forecast by Application (2022-2027)
Table 132. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 133. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share Forecast by Application (2022-2027)
Table 134. Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 135. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share Forecast by Region (2022-2027)
Table 136. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 137. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share Forecast by Region (2022-2027)
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-Invasive Blood Glucose Monitoring Devices
Figure 2. Global Non-Invasive Blood Glucose Monitoring Devices Market Share by Type in 2020 & 2027
Figure 3. MIR/NIR (Mid/Near Infrared Spectroscopy) Product Picture
Figure 4. Raman Spectroscopy Product Picture
Figure 5. Occlusion Spectroscopy Product Picture
Figure 6. Optical Coherence Tomography Product Picture
Figure 7. Photoacoustic Spectroscopy Product Picture
Figure 8. Electromagnetic Product Picture
Figure 9. Fluorescence Product Picture
Figure 10. Other Product Picture
Figure 11. Global Non-Invasive Blood Glucose Monitoring Devices Market Share by Application in 2020 & 2027
Figure 12. Hospitals
Figure 13. Clinics
Figure 14. Home Care Settings
Figure 15. Other
Figure 16. Global Non-Invasive Blood Glucose Monitoring Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Non-Invasive Blood Glucose Monitoring Devices Market Size 2016-2027 (US$ Million)
Figure 18. Global Non-Invasive Blood Glucose Monitoring Devices Sales 2016-2027 (K Units)
Figure 19. Global Non-Invasive Blood Glucose Monitoring Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Non-Invasive Blood Glucose Monitoring Devices Sales Share by Manufacturers in 2020
Figure 21. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Non-Invasive Blood Glucose Monitoring Devices Players: Market Share by Revenue in 2020
Figure 23. Non-Invasive Blood Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Region (2016-2021)
Figure 25. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Region in 2020
Figure 26. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Region (2016-2021)
Figure 27. Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Region in 2020
Figure 28. U.S. Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. China Taiwan Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. UAE Non-Invasive Blood Glucose Monitoring Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Non-Invasive Blood Glucose Monitoring Devices by Type (2016-2021)
Figure 51. Sales Market Share of Non-Invasive Blood Glucose Monitoring Devices by Application (2016-2021)
Figure 52. Sales Market Share of Non-Invasive Blood Glucose Monitoring Devices by Application in 2020
Figure 53. Revenue Share of Non-Invasive Blood Glucose Monitoring Devices by Application (2016-2021)
Figure 54. Revenue Share of Non-Invasive Blood Glucose Monitoring Devices by Application in 2020
Figure 55. Manufacturing Cost Structure of Non-Invasive Blood Glucose Monitoring Devices
Figure 56. Manufacturing Process Analysis of Non-Invasive Blood Glucose Monitoring Devices
Figure 57. Non-Invasive Blood Glucose Monitoring Devices Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed